Arteris, Inc. · NASDAQ:AIP

Arteris — Q2 2025 Earnings Presentation

13 slides from Arteris's earnings presentation, Aug 5, 2025

  1. Slide 1: Arteris 2Q 2025 Earnings Presentation

    Arteris 2Q 2025 Earnings Presentation Charlie Janac Nick Hawkins CEO CFO August 5, 2025 1 © 2025 Arteris, Inc.

  2. Slide 2: Disclaimer

    Disclaimer This presentation and the accompanying oral presentation have been prepared by Arteris, Inc. ("Arteris“ or “the "Company") for informational purposes only and not for any other purpose. Nothing contained in this presentation is, or should be construed as, a recommendation, promise or repr

  3. Slide 3: 2Q Business Highlights (1 of 2)

    2Q Business Highlights (1 of 2)  Achieved $69.1 million ACV plus Royalties and $99.3 million RPO, increases of 15% and 28% Y/Y respectively; both record highs for Arteris  Recognized in the 8th annual AI Breakthrough Awards, with FlexGen winning the “AI Engineering Innovation Award”  Announced th

  4. Slide 4: 2Q Business Highlights (2 of 2)

    2Q Business Highlights (2 of 2) AMD licensed Arteris FlexGen smart network-on-chip IP for its chiplets powering AI, across the company’s broad portfolio which spans from data centers to edge and end devices Renesas is leveraging Arteris multi-die technology in its R-Car Gen 5 SoC platform for advanc

  5. Slide 5: 2Q 2025 Results: Revenue, ACV + Royalties, RPO, Gross Profit

    2Q 2025 Results Revenue, ACV + Royalties, RPO, Gross Profit 2Q 2024 1Q 2025 2Q 2025 Guidance 2Q 2025 Revenue $14.6M $16.5M $16.1M - $16.5M $16.5M (+13% Y/Y) ACV + $69.1M $60.1M $66.8M $66M - $70M Royalties (+15% Y/Y) RPO $77.5M $88.9M N/A $99.3M (+28% Y/Y) Non-GAAP $13.4M $15.3M $15.0M N/A Gross Pro

  6. Slide 6: 2Q 2025 Results: Operating Expenses, Operating Income (Loss)

    2Q 2025 Results Operating Expenses, Operating Income (Loss) 2Q 2024 1Q 2025 2Q 2025 Guidance 2Q 2025 Operating Non-GAAP*: $16.8M Non-GAAP*: $18.4M Non-GAAP*: $18.6M N/A (+10% Y/Y) Expenses GAAP: $20.6M GAAP: $22.7M GAAP: $23.0M Operating Non-GAAP*: ($3.5M) Non-GAAP*: ($3.5M) Non-GAAP*: ($3.2M) Non-G

  7. Slide 7: 2Q 2025 Results: Free Cash Flow, Cash

    2Q 2025 Results Free Cash Flow, Cash 2Q 2024 1Q 2025 2Q 2025 Guidance 2Q 2025 Free Cash $0.3M $2.7M ($5M) – $0M ($2.8M) Flow* Cash, Cash Equivalents & $53.9M $55.1M N/A $53.9M Investments *Non-GAAP measure: See appendix for reconciliation to closest GAAP measure 7 © 2025 Arteris, Inc.

  8. Slide 8: Guidance

    Guidance 3Q 2025 Guidance FY 2025 Guidance ACV + Royalties1 Revenue2 ACV + Royalties3 Revenue4 $69.5M - $72.5M $16.8M - $17.2M $72M - $78M $66M - $70M Non-GAAP Op. Free Cash Flow Non-GAAP Op. Free Cash Flow Income Income ($4M) – ($3M) $0.5M – $3.5M ($15.5M) – ($10.5M) $1M – $7M 1. 71M at the midpoin

  9. Slide 9: Appendix - Non-GAAP Financial Measures

    Appendix - Non-GAAP Financial Measures To supplement our financial results, which are prepared and presented in accordance with GAAP, we use certain non-GAAP financial measures, as described below, to understand and evaluate our core performance. These non-GAAP measures, which may be different than

  10. Slide 10: Appendix - GAAP To Non-GAAP Reconciliation

    Appendix - GAAP To Non-GAAP Reconciliation Gross profit Three Months Ending: In $ thousands June 30, March 31, June 30, 2024 2025 2025 Revenue 14,575 16,532 16,502 Gross profit 13,117 15,006 14,760 Add: Stock-based compensation expense included in cost of 186 205 232 revenue Amortization of acquired

  11. Slide 11: Appendix - GAAP To Non-GAAP Reconciliation

    Appendix - GAAP To Non-GAAP Reconciliation Operating expenses Three Months Ending: In $ thousands June 30, March 31, June 30, 2024 2025 2025 Operating expenses 20,558 22,714 23,008 Less: Stock-based compensation expense 3,574 4,108 4,265 Amortization of acquired intangible assets 142 167 167 Non-GAA

  12. Slide 12: Appendix - GAAP To Non-GAAP Reconciliation

    Appendix - GAAP To Non-GAAP Reconciliation Operating income (loss) Three Months Ending: In $ thousands June 30, March 31, June 30, 2024 2025 2025 Operating Income (Loss) (7,441) (7,708) (8,248) Add: Stock-based compensation expense 3,760 4,313 4,497 Amortization of acquired intangible assets 192 217

  13. Slide 13: Appendix - Free Cash Flow

    Appendix –Free Cash Flow Three Months Ending: In $ thousands June 30, March 31, June 30, 2024 2025 2025 Net cash provided by (used in) operating activities 311 2,860 (2,485) Less: Purchase of property and equipment 47 183 355 Free cash flow 264 2,677 (2,840) 13 © 2025 Arteris, Inc.

Arteris — Q2 2025 Earnings Presentation on 6ix